A significant drop in stock price raises concerns for investors.
Apotex Health Corp (APTX.TO) experienced a sharp decline in its stock price during yesterday's session, closing down 5.94%. This downturn has left many investors questioning the company's stability and future prospects.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.42B
52W high
$40.11
52W low
$26.01
1W change
-1.36%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 35.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+35.5% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$30.54
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.7%
Annualized
90-Day Vol
47.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$25.55
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$28.78 | C$24.50 – C$33.80 |
| 60 trading days | C$27.11 | C$21.59 – C$34.05 |
| 90 trading days | C$25.55 | C$19.33 – C$33.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent drop in Apotex's stock price underscores the volatility in the pharmaceutical sector, especially for companies with upcoming earnings reports.
Stock Price Decline of 5.94%
Apotex's market cap now stands at approximately CA$7.42 billion, reflecting investor concerns following the stock's decline.
Bull case
Investors might see potential in Apotex's upcoming financial results announcement. This could shed light on the company's performance and future direction, possibly reassuring those worried about the recent drop.
Bear case
The significant drop in stock price raises red flags about investor confidence. It could indicate deeper issues within the company, especially given its negative profit margin.
Stock Performance Overview
Advertisement
Apotex Health Corp's stock closed at CA$30.54 yesterday, marking a significant decrease of 5.94%. This decline reflects broader market trends and specific investor sentiment towards the company as it prepares for its upcoming earnings announcement.
Market Reactions and Future Outlook
The decline in Apotex's stock has prompted discussions among investors about the company's financial health. With a profit margin of -0.0085, the company faces challenges that could impact its upcoming financial results. Investors are advised to monitor the situation closely as the announcement date approaches.
Upcoming Financial Results
Apotex is set to release its second quarter Fiscal 2027 financial results on November 12, 2026. This announcement could be a pivotal moment for the company, potentially influencing its stock price and investor confidence in the following weeks.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
